Polyclonal antibodies directed against the preS2 and S domains of the woodchuck hepatitis virus (WHV) envelope proteins were prepared using synthetic peptides and fusion polypeptides as immunogens. They were tested by immunoblotting and immunoprecipitation of infected woodchuck sera and lysates of a eukaryotic cell line expressing WHV envelope proteins. Only one anti-peptide serum directed against the preS2 domain was reactive with WHV envelope proteins, recognizing the preS2 and preS1 proteins by their preS2 epitopes. With recombinant fusion proteins we generated several anti-S sera, which recognized all envelope proteins, and anti-preS2 antisera, which recognized the preS proteins. Results obtained with our antisera showed that sera of infected woodchucks lack the low glycosylated form (GP33) of the preS2 protein, unlike human hepatitis B virus.
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Hepadnaviruses have small genomes and maximize their coding potential by using overlaps in different reading frames and by encoding more than one protein in the same open reading frame (ORF). This is especially true for the ORF encoding the S or major surface protein. The sequence encoding the S protein is preceded by a large open in-frame sequence capable of encoding two additional proteins, preS1 and preS2. The S and preS proteins have a common C terminus and a variable N terminus, depending on the initiation codon used.
Several studies show that the preS sequences of hepatitis B virus (HBV) play important roles in the restricted host range of the virus (Schaeffer & Sninsky, 1984) , in its specific binding to a hepatocyte receptor (for a review see Howard, 1986) and in the secretion of surface antigen particles into the extracellular medium (Ou & Rutter, 1987) . Analogous roles are assumed for the preS sequences of woodchuck hepatitis virus (WHV) (Schaeffer et al., 1986) , the animal hepadnavirus most closely related to HBV in both genome structure and pathology. However, there are few reports on the possible roles of the preS sequences of WHV (Pohl et al., 1986) . Such studies require a panel of antibodies directed specifically against the S and preS domains of WHV.
We have used synthetic peptides and recombinant proteins to generate such antisera. Both approaches have ~'Present address: UPR 2420 CNRS, Centre de G6n&ique Mol6culaire, avenue de la Terrasse, 91198 Gif-sur-Yvette, France advantages and drawbacks. Synthetic peptides are pure and the specificity of the antiserum is known with some precision. However, the choice of peptide is critical and it is often difficult to generate high titre antisera. Because of the limited number of epitopes present, anti-peptide sera are vulnerable to viral strain differences. Recombinant proteins must be purified but, if expression is sufficient, this does not pose major problems. These proteins are usually good immunogens, producing high titre antisera directed against a wider range of epitopes. Polymerase chain reaction (PCR) cloning techniques now enable the cloning of any sequence, avoiding the limitations imposed by the need to use available restriction enzyme sites. The major drawback is that expression of recombinant proteins remains empirical, depending on a combination of the vector used, the recombinant protein itself and the host strain used for expression.
Five different peptides were prepared ( Fig. 1) , chosen from potentially immunogenic regions determined by predictions of relative hydrophobicity (Hopp & Woods, 1981) and local secondary structure (Chou & Fasman, 1978) . Two were derived from the hydrophilic central region of the S protein which is well conserved between HBV and WHV; antisera directed against HBV surface proteins have been produced using peDtides similar to ours (Lerner et aL, 1981 ; Gerin et al., 1983) . Two other peptides were derived from the preS1 region and one was derived from the preS2 region. Galibert et al., 1982) of each ATG determining the three envelope proteins and the termination codon (TAA) of the S protein. Arrows underneath the line delineate the regions chosen for the synthesis of fusion protein or peptide numbering as in Galibert et al. (1982) , chosen for the synthesis of peptides. Numbers above these arrows correspond to the number of the peptide as referred to in the text. The designations of useful antisera obtained are indicated in brackets. The numbers at the end of each arrow give the amino acid boundary of each fusion protein or peptide numbering as in Galibert et al., (1982) , starting with the initiation codon methionine of each protein.
from Neosystem Laboratories and peptides 3 to 5 were from M. Rholam, N. Brakch and P. Cohen (UER de Biochimie, Universit6 Paris VI, France). Peptides 3 and 5 were synthesized with a cysteine at their C terminus to allow their coupling to ovalbumin (Pain & Surolia, 1981) . For construction of recombinant protein expression plasmids, the expression vectors used included pLc24 (Remaut et al., 1981) and its derivatives, pCo1124 and pNru24 (A. Kay et al., unpublished results). These vectors produce recombinant proteins fused to about 100 amino acids (aa) (pLc24, pCo1124) or 16 aa (pNru24) of the N terminus of phage MS2 polymerase. DNA fragments containing portions of the preS and S regions of WHV ( Fig. 1 ) with additional restriction enzyme cloning sites at their extremities were prepared by PCR (Saiki et al., 1988 ) and cloned into one or several expression vectors. Constructions were verified by sequencing. Not all the regions cloned could be expressed sufficiently, notably neither the entire preS1 region nor its C-terminal portion. All other portions chosen were successfully expressed. The N-terminal portion of preS1 (aa 1 to 73) was expressed from pCo1124, the entire preS2 region (aa 1 to 60) and the N terminus of the S protein (aa 1 to 82) from pLc24 and the central portion of the S protein (aa 96 to 166) from both pLc24 and pNru24. Recombinant proteins were purified by preparative SDS-PAGE. Antisera were raised as described previously (Gazin et al., 1986) in at least two rabbits per immunogen. Sera were tested by ELISA, using the appropriate immunogen, and by immunoblotting of infected woodchuck sera (WHs ÷ sera) and total cell extracts of a cell line stably producing WHV surface proteins, 3cpW32; this cell line will be described fully elsewhere (B.-M. Shamoon et al., unpublished results). Briefly, CHO dhfrcells (Urlaub & Chasin, 1980) were transfected with plasmid pSWS, derived from plasmid pSVS (Michel et al., 1984) , by deleting all HBV sequences and replacing them with a fragment (nucleotides 2975 to 2191) containing all the preS1, preS2, S and X sequences of WHV. The plasmid contains a functional dhfr gene and the preS and S sequences are under the control of the simian virus 40 (SV40) early promoter and/or endogenous WHV promoters. CHO dhfr ÷ clones producing WHV envelope proteins were selected in ~MEM. A control cell line, 6cpRV, transfected with a plasmid derived from pSWS by deletion of all WHV sequences, was established in the same manner. Immunoblotting was carried out as described previously (Gazin et al., 1986) ; the presence of antibodies was revealed with l zsIlabelled Protein A (Amersham).
We found that the peptides we had chosen were very ineffective as immunogens. Only two animals yielded sera with high titres in the ELISA test. Furthermore, only the serum from an animal injected with peptide 3 (aa 16 to 29 of the preS2 region) showed reactivity in the more functional test of immunoblotting of WHV surface proteins in WHs ÷ sera or 3cpW32 cell extracts. A possible explanation for the relative lack of success with the peptide approach is that the criteria used for the choice of the peptides also predict the WHV surface proteins to be less antigenic than their HBV counterparts.
All recombinant proteins induced sera with high titres in the ELISA test. However, sera elicited by the protein containing the N-terminal portion of preS1 were ineffective in the immunoblotting tests. Again, this may be due to the low predicted immunogenicity of this region. All other recombinant proteins that we could express and purify elicited useful antisera. We obtained six recombinant protein antisera, three directed against the central portion of the S protein (aa 96 to 166), two expressed from pLc24 and one from pNru24, one serum directed against the N terminus of the S protein (aa 1 to 82) and two directed against the entire preS2 region, plus one anti-preS2 peptide (aa 16 to 29) serum.
All four anti-S sera reacted in a similar manner. This is shown for serum 'O' in Fig. 2 . This is the strongest anti-S serum and was elicited by a recombinant central S protein expressed from pNru24, containing only a few amino acids contributed by the vector. In WHs ÷ sera (Fig. 2a) , this rabbit antiserum recognized a doublet of proteins corresponding to the S proteins (P24/GP27), and a doublet in the size range corresponding to preS1 proteins (P45/GP47). However, where one would expect a doublet of preS2 proteins (GP33/GP36), only one band was detected, and this only in some infected sera. For reasons discussed below we believe that this band corresponds to the fully glycosylated form of preS2, GP36. A band of about 70K was also variably but systematically detected. This may correspond to a multimeric form of WHV surface proteins resistant to denaturation, such as has been described for HBV (Petit et al., 1987) . The specificity of the reactivity is shown in Fig. 2(b) . Preincubation of the antiserum with an unrelated protein (HBx protein expressed from pLc24) had no effect whereas preincubation with a central S protein expressed from pLc24 significantly reduced reactivity. Reactivity was also reduced by preincubation with WHs ÷, but not uninfected woodchuck serum (not shown). Immunoblotting with the antiserum on extracts of the WHV surface protein-producing cell line is shown in Fig. 2(c) . The serum detected not only the two S proteins but also a doublet of preS2 proteins, showing that the inability to detect GP33 was not due to a deficiency of the antiserum. None of the anti-S sera could detect preSl proteins in the cell extracts. The reactivity of an anti-recombinant preS2 protein serum, 'D', is shown in Fig. 3 . In WHs ÷ sera (Fig. 3a) , the rabbit antiserum strongly recognized the doublet of preS1 proteins but, again, only one protein band was recognized in the size range expected for preS2 proteins. The reactivity of the antiserum was markedly reduced by preincubation with the synthetic preS2 peptide (Fig. 3 b) , indicating that the majority, but not all, of the antibodies are directed against epitopes contained in aa 16 to 29 of the preS2 region. Fig. 3 (c) shows simultaneous immunoblotting of both WHs ÷ serum and 3cpW32 cell lysate. Only the doublet of preS2 proteins was efficiently recognized in the cell extract and the comigration showed that in woodchuck sera it was indeed the GP36 form of preS2 which was present. Both serum 'D' and the anti-preS2 peptide serum also showed weak reactions which were difficult to reproduce, with what could be preS1 proteins in the 3cpW32 cell extracts. The reasons for this lack of expression of preS1 proteins in the cell lines are not clear. Northern blots revealed two major WHV-specific RNA bands with sizes consistent with transcription from the endogeneous WHV S promoter and from the pSWS plasmid SV40 promoter (data not shown).
To be fully useful, the antisera should recognize WHV surface proteins in their native form. To test this we used the antisera to immunoprecipitate WHV envelope particles from infected sera and 3cpW32 cell lysates; all our antisera could do this. Infected sera were first immunoprecipitated with antisera and Protein ASepharose CL-4B (Pharmacia) and the immunoprecipitates were subjected to SDS-PAGE and immunoblotted. This is shown in Fig. 4(a) for immunoprecipitation with anti-central S serum 'O' and subsequent immunoblotting with the same serum. Since particles were being precipitated, the profiles obtained were qualitatively similar whether the antiserum used for immunoprecipi- Fig. 4(b) , it is evident that the antipreS2 serum, 'D', precipitated the two major surface proteins, showing that the 3cpW32 cell line efficiently packages W H V surface proteins into particles. The GP33 form of preS2 was also present. Surprisingly, none of the sera precipitated the fully glycosylated form of preS2, GP36. Perhaps the conditions used for radiolabelling inhibited the second glycosylation event or this event occurs on a time scale longer than the period used for labelling. Consistent with the results of i m m u n o b l o tting, preS1 proteins could not be detected.
In conclusion, we have p r e p a r e d a panel of antisera directed against various parts of W H V surface proteins. These antisera are effective in both i m m u n o b l o t t i n g and i m m u n o p r e c i p i t a t i o n , thus providing well characterized antibodies capable of recognizing all k n o w n forms of W H V surface proteins and having a wide range of uses. These antisera show that, unlike viral particles from HBV-infected serum, which contain a p p r o x i m a t e l y equal amounts of both forms of preS2 ( H e e r m a n et aL, 1984) , viral particles in infected woodchuck sera lack the singly glycosylated form, GP33. W e are at present studying the profiles o f surface proteins synthesized in infected w o o d c h u c k liver to d e t e r m i n e whether the lack of GP33 in serum viral particles reflects either preferential biosynthesis of the doubly glycosylated form of preS2 or whether this form is preferentially incorporated into excreted viral particles.
